One hundred and seventeen young patients diagnosed with breast cancer were eligible to be included in the current analysis, of whom fifteen had at least one pregnancy after breast cancer treatment; eleven were of the BRCA-wildtype and four were BRCA-positive (two patients were BRCA1-positive and two patients were BRCA2-positive). The gene discussed is BRCA2; the disease is breast cancer.